All Comments by Sanjay Pimplikar

  1. Can Diet Influence Alzheimer’s Disease Biomarkers?
  2. Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration.
  3. Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses.
  4. Novel mediators of amyloid precursor protein signaling.
  5. APP Tail May Wag DNA Repair Pathway
  6. Keystone: Death Receptor Ligand—New Role for APP, New Model for AD?
  7. Research Brief—Flurizan Fails Final Hurdle, Company Discontinues Drug
  8. San Diego: Oligomers Live Up to Bad Reputation, Part 1
  9. Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1.
  10. APP Family: Clues to Function in Health and AD
  11. How Does Aβ Do Harm? New Clues on Insulin Signaling, Spines, Inflammation
  12. The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice.
  13. Presenilin/gamma-secretase-dependent processing of beta-amyloid precursor protein regulates EGF receptor expression.
  14. Role of APP phosphorylation in FE65-dependent gene transactivation mediated by AICD.
  15. Gain or Loss of Function—Time to Shake up Assumptions on γ-Secretase in Alzheimer Disease?